FindTrial
Sign In

The Study on Establishing an Early Prediction Model for PNAC in Preterm Infants Based on FGFs and Its Clinical Application

The Study on Establishing an Early Prediction Model for PNAC in Preterm Infants Based on FGFs and Its Clinical Application

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106098
Enrollment
Unknown
Registered
2025-07-17
Start date
2025-07-17
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PNAC in preterm infants

Interventions

PNAC/non-PNAC group:None

Sponsors

Women and Children’s Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Preterm infants with gestational age <32 weeks and birth weight <1,500 g; Continuous parenteral nutrition for 7 days postnatally

Exclusion criteria

Exclusion criteria: Congenital malformations or chromosomal abnormalities; Extrahepatic bile duct dysplasia, intrahepatic bile duct disease, hereditary metabolic disease, etc.; Severe infection; Other systemic complications such as intracranial bleeding, etc.; incomplete information; The child dies or the family asks to forgo treatment.

Design outcomes

Primary

MeasureTime frame
FGFs(FGF1?FGF19?FGF21);The occurrence of PNAC;Gut microbiota and metabolism;—

Secondary

MeasureTime frame
Outcome of PNAC;—

Countries

China

Contacts

Public ContactChaohui Ye

Women and Children’s Hospital of Ningbo University

ych474622@163.com+86 574 8388 7188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026